Here are six recent news updates on gastroenterology and endoscopy companies.
Ashish Nimgaonkar, MBBS, MTech, MS, of John Hopkins University in Baltimore, received the American Gastroenterological Association Research Foundation's AGA-Boston Scientific Career Development Technology & Innovation Award. The award is supported by a grant from Boston Scientific.
David A. Pierce, senior vice president with Boston Scientific, sold 5,000 shares of company stock at an average price of $12.90, according to a WKRB News & Analysis report. The transaction total was $64,500.
Ferring Pharmaceuticals opened its new U.S. Operations center in New Jersey. The new location will house 275 employees.
During the company's first quarter ended Oct. 31, Medivators sales increased 13 percent.
The 21 brokerages covering Salix Pharmaceuticals have given the company's stock a "hold" rating, according to a WKRB News & Analysis report. The company's stock traded down 0.07 percent last week, hitting $105.805.
Seres Health, a clinical-stage therapeutics company, raised $48 million. The Series C round financing will be used to fund a phase 3 trial of its lead drug, SER-109, intended to prevent the recurrence of Clostridium difficile infection.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.